Table 2: Variable associations with SVR.

SVR
( 𝑛 = 2 5 1 )
Response failure
( 𝑛 = 1 0 5 )
𝑃 values

Gender (males%)145 (57.8)52 (49.5) 0.154
Age ≥ 40 years ( 𝑛 %)123 (49.60)80 (77.7)<0.001
IVDU ( 𝑛 %)95 (37.8)16 (15.4)<0.001
Alcohol abuse ( 𝑛 %)27 (11.2)14 (14.1) 0.442
BMI (kg/m2) 2 3 . 1 ± 3 . 8 2 4 . 6 ± 4 . 5 0.035
Overweight ( 𝑛 %)24 (28.6)25 (50.0) 0.013
Genotype distribution<0.001
 Genotype 1111 (45.5)53 (52.5)
 Genotype 217 (7.0)6 (5.9)
 Genotype 398 (40.2)15 (14.9)
 Genotype 418 (7.4)27 (26.7)
High viral load ( 𝑛 %)39 (40.6)28 (45.8) 0.515
Abnormal ALT ( 𝑛 %)236 (96.7)95 (95.0) 0.447
Abnormal AST ( 𝑛 %)199 (86.1)77 (86.5) 0.931
Hepatic steatosis ( 𝑛 %)64 (25.7)49 (46.7)<0.001
Severe inflammation ( 𝑛 %)9 (3.8)8 (8.5) 0.080
Advanced fibrosis ( 𝑛 %)26 (10,5)30 (28,6)<0.001
Cirrhosis ( 𝑛 %)7 (2,8)14 (13,3)<0.001
Type of IFN 0.987
 PegIFNα-2a ( 𝑛 %)69 (28.6)27 (28.7)
 PegIFNα-2b ( 𝑛 %)172 (71.4)67 (71.3)
Dosage adherence ( 𝑛 %)173 (80.8)60 (82.2) 0.799